Mochida Intends to Carve Out Market Share with 1st G-Lasta Biosimilar

December 13, 2023
Junichi Sakaki, Member of the Board, Senior Executive Managing Officer, Mochida Mochida Pharmaceutical looks to penetrate the market with its Pegfilgrastim BS, Japan’s first biosimilar version of long-acting G-CSF agent G-Lasta launched last month, by touting the product’s comparability with...read more